Apotheek Jasmijn SRL
Apotheek Jasmijn reported total assets of 430,192 € at the end of the 2025 financial year (annual accounts filed with the NBB on 19 Jun 2026).
The score of Apotheek Jasmijn shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +30 % Total assets +142 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Apotheek Jasmijn's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 25,149 € | ||||
| Equity | 162,320 € | ||||
| Cash | 69,755 € | ||||
| EBITDA | 52,789 € | ||||
| Total assets | 430,192 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 19 Jun 2026
- Year ended 31 Dec 2024filed on 04 Aug 2025
- Year ended 31 Dec 2023filed on 12 Jul 2024
- Year ended 31 Dec 2022filed on 17 Jul 2023
- Year ended 31 Dec 2021filed on 14 Jul 2022
Apotheek Jasmijn's financial analysis
- Solvency37.7%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Apotheek Jasmijn
Apotheek Jasmijn's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0847.647.663
- VAT number
- BE0847647663
- Peppol
- Registered · 0208:0847647663 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 09 Jul 2012
- Registered office
- 2140 Antwerp
- Latest accounts
- 2025 · filed on 19 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Apotheek Jasmijn (SRL) has been based in Antwerp since 2012, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 25,149 € and equity of 162,320 €; its revenue is not published. Its solvency stands at 37.7%, below the median of its sector (44.2%).
Companies similar to Apotheek Jasmijn
Companies in the same business, of comparable size and area, outside its group.
- Sobegapharma Manufacture of basic pharmaceutical products Mons · balance sheet €1.04m
- Jeandarme Manufacture of pharmaceutical preparations Sint-Truiden · balance sheet €1.60m
- Pharmacie Courouble Manufacture of basic pharmaceutical products Schaerbeek · balance sheet 129,672 €
- Boiron Manufacture of pharmaceutical preparations Evere · balance sheet €9.25m
- Pharmahealth Retail sale of pharmaceutical products Zottegem · balance sheet 607,296 €
- Pharma Werbomont Retail sale of pharmaceutical products Ferrières · balance sheet €1.35m
- Codema Pharma Retail sale of pharmaceutical products Brussels · balance sheet 375,959 €
- Tannhauser Pharaescos Retail sale of pharmaceutical products Koekelberg · balance sheet 292,153 €
Frequently asked questions about Apotheek Jasmijn
What is the revenue of Apotheek Jasmijn?
Apotheek Jasmijn files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Apotheek Jasmijn?
In Belgium, the VAT number is the company number prefixed with BE: BE0847647663 for Apotheek Jasmijn, if the company is VAT-registered. Its company number (CBE) is 0847.647.663.
Where is the registered office of Apotheek Jasmijn?
According to the CBE register, the registered office of Apotheek Jasmijn is in 2140 Antwerp.
What is the equity of Apotheek Jasmijn?
At the close of the 2025 financial year, the equity of Apotheek Jasmijn amounts to 162,320 €, a solvency of 37.7% of total assets.
Who manages Apotheek Jasmijn?
The register lists 2 active mandates at Apotheek Jasmijn. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Apotheek Jasmijn
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →